A possible correlation between Vitamin D metabolism defects and MS and between Vitamin D3 and remyelination have been envisaged [60, 61] through Vitamin D Receptor (VDR) dimerization with RxRγ [6]. This evidence concerns the gene VDR and myeloid sarcoma.